GE HealthCare (GEHC) CTO reports 847-share tax withholding event

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Chief Technology Officer Taha Kass-Hout reported a routine tax-related share withholding. On February 1, 2026, 847 shares of common stock were withheld at $78.97 per share to cover tax obligations tied to vesting restricted stock units.

After this transaction, Kass-Hout beneficially owns 64,103 shares of GE HealthCare common stock in direct ownership. This filing reflects an administrative tax settlement rather than an open-market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kass-Hout Taha

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/01/2026		F		847(1)	D	$78.97	64,103	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did GE HealthCare (GEHC) report for Taha Kass-Hout?

GE HealthCare reported that CTO Taha Kass-Hout had 847 shares withheld to cover taxes on vested restricted stock units. The shares were valued at $78.97 each and represent a routine tax-withholding event, not an open-market sale or discretionary trade.

How many GEHC shares were involved in Taha Kass-Hout’s February 2026 Form 4?

The Form 4 shows 847 GE HealthCare common shares were withheld on February 1, 2026. These shares satisfied tax withholding obligations from restricted stock unit vesting, rather than being sold on the open market, according to the transaction code and accompanying footnote.

At what price were Taha Kass-Hout’s GEHC shares withheld for taxes?

The withheld GE HealthCare shares were valued at $78.97 per share. This price applies to the 847 common shares used to satisfy tax obligations arising from the vesting of restricted stock units, as disclosed in the Form 4 filing and explanation of responses.

How many GE HealthCare (GEHC) shares does Taha Kass-Hout own after this transaction?

Following the tax-withholding transaction, Taha Kass-Hout beneficially owns 64,103 GE HealthCare common shares. The ownership is reported as direct, meaning the shares are held in his name rather than through an intermediary entity, according to the Form 4 disclosure table.

Was Taha Kass-Hout’s GEHC Form 4 transaction a sale on the open market?

No, the Form 4 identifies the transaction as share withholding for taxes, not an open-market sale. The filing explains that 847 shares were withheld to satisfy tax obligations from restricted stock unit vesting, a common administrative step in equity compensation programs.